The visit of the Ukrainian delegation headed by Deputy Prime Minister for the reintegration of the temporarily occupied territories of Ukraine Oleksiy Reznikov to Israel resulted in the solution of a number of important issues for the country, in particular, to overcome the COVID-19 pandemic. The corresponding statement was made by the Ambassador of Ukraine to Israel Yevhen Korniychuk on his Facebook page.
“I want to thank all the delegates for their active position in the work and significant contribution to the issue of reaching agreements in cooperation with Israel. Together, we solved a number of important issues for our country, in particular, interaction in the field of trade, investment, medicine and in overcoming the COVID-19 pandemic,” the diplomat said.
He said that an important aspect of the negotiations was the completion by Israel of the second phase of trials of its COVID-19 vaccine in mid-summer.
“The Ukrainian side proposed to conduct the third stage of testing in Ukraine with the subsequent possibility of producing a vaccine, including at our facilities. Israel is still studying this proposal and, I hope, it will be received positively. It is already clear that the pandemic of coronavirus infection will drag on for more than one year in the world. And the production of the vaccine, its availability for our citizens is a very sensitive and important issue for us,” Korniychuk said.
Pharmaceutical manufacturers of Ukraine register clinical trials of medicines for the treatment of coronavirus (COVID-19), Health Minister Maksym Stepanov has said.
“There are internal enterprises that register clinical trials of medicines, which they produce in our country. Currently, they are Farmak, Borschahivsky Chemical Pharmaceutical Plant, Darnitsa pharmaceutical company, Biopharma and Interchem. They are trying to create medicines to treat COVID-19, including symptomatic ones. For example, Darnitsa brought in a substance for the production of hydroxychloroquine, while Biopharma registered a clinical trial of Bioven,” he said during a press briefing in Kyiv on Wednesday, May 13.